Clinical trials
Phase 2 Hypertension, Pulmonary trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 6 |
| Completed | 5 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Actelion | 3 |
| GlaxoSmithKline | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 1 |
| AllRock Bio, Inc. | 1 |
| Bayer | 1 |
| Fondation Hôpital Saint-Joseph | 1 |
| Gilead Sciences | 1 |
| Heidelberg University | 1 |
| Liquidia Technologies, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 18 |
| Pulmonary Arterial Hypertension | 6 |
| Familial Primary Pulmonary Hypertension | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Lung Diseases, Interstitial | 2 |
| Cardiovascular Diseases | 1 |
| Connective Tissue Diseases | 1 |
| Fibrosis | 1 |
| Hereditary Sensory and Autonomic Neuropathies | 1 |
| Hypertension | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.